publication venue for
- Characterization of the Selective Indoleamine 2,3-Dioxygenase-1 (IDO1) Catalytic Inhibitor EOS200271/PF-06840003 Supports IDO1 as a Critical Resistance Mechanism to PD-(L)1 Blockade Therapy.. 17:2530-2542. 2018
- NEO212, temozolomide conjugated to perillyl alcohol, is a novel drug for effective treatment of a broad range of temozolomide-resistant gliomas.. 13:2004-17. 2014
- Perillyl alcohol for the treatment of temozolomide-resistant gliomas.. 11:2462-72. 2012
- Notch inhibition in Kaposi's sarcoma tumor cells leads to mitotic catastrophe through nuclear factor-kappaB signaling.. 6:1983-92. 2007